Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Moscow Exchange summarized the results of trading in January

2/4/25 MOEX

KEMP reports for 2024 by RAS

2/4/25 KEMZP

Samolet started realization of the first project in Ufa

2/4/25 SMLT

Whoosh fleet in South America has reached 12,000 scooters

2/4/25 WUSH

Binnopharm Group's export revenue reached ₽3.8 billion

2/4/25 AFKS

MTS Live will open a concert venue in St. Petersburg

2/4/25 MTSS

Softline created a sub-holding for IPO of subsidiaries

2/3/25 SOFL

Polyus shareholders approve share split

2/3/25 PLZL

Yakovlev reported for 2024 by RAS

2/3/25 IRKT

Board of Directors of Diasoft recommended dividends

2/3/25 DIAS